Tumor growth was significantly inhibited in the mice injected with the CD117+CD44+-shHOTAIR compared with the mice injected with the CD117+CD44+-scramble, and the tumor volume was significantly reduced in the former (p<0.01) (Figure 5D). Here, CD44 is linked to neoplasm.